MICHAEL D. CANNON - 12 Nov 2025 Form 4 Insider Report for Moleculin Biotech, Inc. (MBRX)

Role
Director
Signature
/s/ Jonathan Foster by Power of Attorney
Issuer symbol
MBRX
Transactions as of
12 Nov 2025
Transactions value $
$0
Form type
4
Filing time
14 Nov 2025, 16:06:17 UTC
Previous filing
06 Nov 2024
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
CANNON MICHAEL D Director C/O MOLECULIN BIOTECH, INC., 5300 MEMORIAL DR., SUITE 950, HOUSTON /s/ Jonathan Foster by Power of Attorney 14 Nov 2025 0001203602

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MBRX Stock Options (right to buy) Award +150K +978.09% 165K 12 Nov 2025 Common Stock 150K $0.49 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options set forth in this table vest on November 12, 2026, subject to the grantee's continued service on the Company's Board of Directors on each vesting date.
F2 The options were issued in connection with the reporting person's Board of Director service to the Company.